| P2093 | author name string | Yuji Mishina | |
| | Nobuhiro Kamiya | |
| P2860 | cites work | Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis | Q21145242 |
| | Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin | Q22253980 |
| | Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST) | Q24290838 |
| | Mutations in bone morphogenetic protein receptor 1B cause brachydactyly type A2 | Q24296798 |
| | SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor | Q24303393 |
| | Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation | Q24311588 |
| | Mutation of the bone morphogenetic protein GDF3 causes ocular and skeletal anomalies | Q24311933 |
| | Osteoprotegerin: a novel secreted protein involved in the regulation of bone density | Q24313918 |
| | The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4 | Q24315313 |
| | A human chondrodysplasia due to a mutation in a TGF-beta superfamily member | Q24320410 |
| | A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva | Q24321505 |
| | Molecular recognition of BMP-2 and BMP receptor IA | Q24324472 |
| | Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein | Q24536172 |
| | Bmpr1a and Bmpr1b have overlapping functions and are essential for chondrogenesis in vivo | Q24555732 |
| | BMP type I receptor inhibition reduces heterotopic [corrected] ossification | Q24611307 |
| | Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin | Q24612297 |
| | Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease | Q24679575 |
| | BMP receptor signaling is required for postnatal maintenance of articular cartilage | Q24801945 |
| | beta-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin | Q28190343 |
| | Identification of the ligand-binding site of the BMP type IA receptor for BMP-4 | Q28203953 |
| | Dickkopf1 is required for embryonic head induction and limb morphogenesis in the mouse | Q28204667 |
| | Receptors for the TGF-β family | Q28210923 |
| | A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population | Q28214572 |
| | The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma | Q28236113 |
| | Mechanism of activation of the TGF-beta receptor | Q28245861 |
| | Mutations in CDMP1 cause autosomal dominant brachydactyly type C | Q28248352 |
| | Bone: formation by autoinduction | Q28251545 |
| | Bone morphogenetic protein type IA receptor signaling regulates postnatal osteoblast function and bone remodeling | Q28257036 |
| | Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2 | Q28283345 |
| | Sclerostin inhibition of Wnt-3a-induced C3H10T1/2 cell differentiation is indirect and mediated by bone morphogenetic proteins | Q28293474 |
| | Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse | Q28296363 |
| | Bone morphogenetic proteins | Q28300236 |
| | Incomplete penetrance and phenotypic variability characterize Gdf6-attributable oculo-skeletal phenotypes | Q28306123 |
| | Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation | Q28505419 |
| | Genetic interaction between Wnt/beta-catenin and BMP receptor signaling during formation of the AER and the dorsal-ventral axis in the limb | Q28507152 |
| | BMP canonical Smad signaling through Smad1 and Smad5 is required for endochondral bone formation | Q28507269 |
| | A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye | Q28508005 |
| | Ectodermal Wnt3/beta-catenin signaling is required for the establishment and maintenance of the apical ectodermal ridge | Q28511730 |
| | Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development | Q28513337 |
| | The type I serine/threonine kinase receptor ActRIA (ALK2) is required for gastrulation of the mouse embryo | Q28587737 |
| | Multiple roles for activin-like kinase-2 signaling during mouse embryogenesis | Q28591124 |
| | Essential role of beta-catenin in postnatal bone acquisition | Q28594492 |
| | Developmental regulation of the growth plate | Q29618969 |
| | Identification of progenitor cells that contribute to heterotopic skeletogenesis | Q30436925 |
| | Beta-catenin and BMP-2 synergize to promote osteoblast differentiation and new bone formation. | Q30440191 |
| | Bmpr1a is required for proper migration of the AVE through regulation of Dkk1 expression in the pre-streak mouse embryo | Q33788035 |
| | BMP signaling and early embryonic patterning. | Q34416108 |
| | Endochondral ossification is required for haematopoietic stem-cell niche formation | Q34902854 |
| | Function of bone morphogenetic protein signaling during mouse development | Q35109473 |
| | Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts. | Q35156225 |
| | A homozygous BMPR1B mutation causes a new subtype of acromesomelic chondrodysplasia with genital anomalies. | Q35448192 |
| | The origins of osteoclasts | Q35808029 |
| | A new subtype of brachydactyly type B caused by point mutations in the bone morphogenetic protein antagonist NOGGIN. | Q35946239 |
| | The role of growth factors and related agents in accelerating fracture healing | Q36486920 |
| | Mutations in BMP4 cause eye, brain, and digit developmental anomalies: overlap between the BMP4 and hedgehog signaling pathways | Q36719098 |
| | Recombinant bone morphogenetic protein-7 as an intracorporal bone growth stimulator in unstable thoracolumbar burst fractures in humans: preliminary results | Q36725835 |
| | Endochondral ossification: how cartilage is converted into bone in the developing skeleton. | Q36894947 |
| | Duplications involving a conserved regulatory element downstream of BMP2 are associated with brachydactyly type A2. | Q37156002 |
| | Disruption of BMP signaling in osteoblasts through type IA receptor (BMPRIA) increases bone mass. | Q37203466 |
| | BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway. | Q37222697 |
| | Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts | Q38307509 |
| | Conditional deletion of BMP7 from the limb skeleton does not affect bone formation or fracture repair | Q40289491 |
| | Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts. | Q40375932 |
| | BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop | Q40621832 |
| | Activated beta-catenin induces osteoblast differentiation of C3H10T1/2 cells and participates in BMP2 mediated signal transduction | Q40676346 |
| | TGFbeta signaling: receptors, transducers, and Mad proteins. | Q41010880 |
| | Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand | Q42507521 |
| | Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia | Q42801302 |
| | BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling | Q45065876 |
| | Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength | Q46186977 |
| | BMPR1A signaling is necessary for hair follicle cycling and hair shaft differentiation in mice. | Q47764614 |
| | Graft resorption with the use of bone morphogenetic protein: lessons from anterior lumbar interbody fusion using femoral ring allografts and recombinant human bone morphogenetic protein-2. | Q51214225 |
| | BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. | Q52002102 |
| | Beta-catenin signaling pathway is crucial for bone morphogenetic protein 2 to induce new bone formation. | Q52002734 |
| | Bone morphogenetic protein signals are required for cartilage formation and differently regulate joint development during skeletogenesis. | Q52120096 |
| | Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. | Q52204129 |
| | rhBMP-2 induces transient bone resorption followed by bone formation in a nonhuman primate core-defect model. | Q53311525 |
| | Expression of Cre recombinase in the developing mouse limb bud driven by aPrxl enhancer | Q64965676 |
| | BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning | Q71817916 |
| | Transcriptional mechanisms in osteoblast differentiation and bone formation | Q73763993 |
| | Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development | Q79822578 |
| | Interbody fusion with allograft and rhBMP-2 leads to consistent fusion but early subsidence | Q79931833 |
| | Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass | Q83924358 |
| P433 | issue | 2 | |
| P304 | page(s) | 75-82 | |
| P577 | publication date | 2011-03-01 | |
| P1433 | published in | BioFactors | Q15767404 |
| P1476 | title | New insights on the roles of BMP signaling in bone-A review of recent mouse genetic studies | |
| P478 | volume | 37 | |